Paediatric asthma: diagnosis and treatment Practice Review figure descriptions and data
Accessible text descriptions and data for figures in the NPS MedicineWise Practice Review for paediatric asthma diagnosis and treatment
What asthma medicines did you prescribe for your patients aged 1–5 years in FY 2018–19?
Data for the first figure in the sample Paediatric asthma Practice Review
|
SABA only (%) |
Low-strength ICS (%) |
Montelukast (%) |
High-strength ICS (%) |
ICS+LABA (%) |
|
|
You |
13 |
13 |
38 |
25 |
25 |
|
Median of GPs in your RA who prescribed one or more asthma medicines for children (aged 1–5) |
50 |
38 |
0 |
0 |
0 |
|
25th percentile of GPs in your RA |
10 |
0 |
0 |
0 |
0 |
|
75th percentile of GPs in your RA |
73 |
67 |
7 |
0 |
0 |
Return to the Practice Review – Paediatric Asthma: diagnosis and treatment
What asthma medicines did you prescribe for your patients aged 6–11 years in FY 2018–19?
Data for the second graph in the sample Paediatric asthma Practice Review
|
SABA only (%) |
Low-strength ICS (%) |
Montelukast (%) |
High-strength ICS (%) |
ICS+LABA (%) |
|
|
You |
17 |
0 |
17 |
17 |
67 |
|
Median of GPs in your RA who prescribed one or more asthma medicines for children (aged 6–11) |
25 |
33 |
0 |
0 |
0 |
|
25th percentile of GPs in your RA |
0 |
13 |
0 |
0 |
0 |
|
75th percentile of GPs in your RA |
50 |
57 |
17 |
20 |
17 |
Return to the Practice Review – Paediatric Asthma: diagnosis and treatment
What was the first preventer you prescribed for your patients aged 1–11 years in FYs 2017–19?
Data for the third graph in the sample Paediatric asthma Practice Review
|
Low-strength ICS (%) |
Montelukast (%) |
High-strength ICS (%) |
ICS+LABA (%) |
|
|
You (n) |
8 |
3 |
10 |
3 |
|
You (%) |
33 |
13 |
42 |
13 |
|
Your RA (%) |
63 |
13 |
12 |
13 |
Return to the Practice Review – Paediatric Asthma: diagnosis and treatment
Age profile of your patients aged 1–11 (1 July 2018 to 30 June 2019)
Data for the age profile graph in the sample Paediatric asthma Practice Review
|
Number of patients |
0–1 (years) |
2–3 (years) |
4–5 (years) |
6–7 (years) |
8–9 (years) |
10–11 (years) |
|
You |
65 |
38 |
26 |
20 |
30 |
25 |
|
25th percentile |
29 |
17 |
15 |
13 |
12 |
7 |
|
75th percentile |
136 |
82 |
71 |
59 |
52 |
32 |
Return to the Practice Review – Paediatric Asthma: diagnosis and treatment
What was the first preventer prescribed by Australian GPs for patients aged 1–11 years in FYs 2017–19?
Data for the bar graph showing aggregated data in different remoteness areas (not included in sample Practice Review)
|
Low-strength ICS (%) |
Montelukast (%) |
High-strength ICS (%) |
ICS+LABA (%) |
|
|
Major city |
63 |
13 |
13 |
12 |
|
Inner regional |
61 |
16 |
13 |
12 |
|
Outer regional |
58 |
14 |
13 |
16 |
|
Remote |
63 |
11 |
12 |
15 |
|
Very remote |
52 |
17 |
15 |
18 |
Return to the Practice Review – Paediatric Asthma: diagnosis and treatment